Pilot study: External surface contamination of gemcitabine and 5-fluorouracil on drug packaging.
Monica KåredalJennie ÖzdemirAndreas TinnertMaria WetterlingMaria HedmerPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
External contamination of ADs are still present at primary drug packagings on the Swedish market. Protection of AD vials by plastic shrink-wrap or a secondary plastic container does not remove the external contamination levels completely. The presence of cross contamination of ADs on drug packagings was also observed.